SMC Spain

SMC Spain

SMC Spain
Position
Topics

What is the status of Hipra's Spanish anticovid vaccine?

The European Medicines Agency (EMA) is still considering the approval of Hipra's SARS-CoV-2 vaccine. In mid-May, Hipra said it was ready to "have the vaccine available in a few days" following EMA approval, which it expected by the middle of this year, but which is being delayed until at least after July, as Elia Torroella, Hipra's R&D and Registration Director, explained at a breakfast briefing organised by the company today. 

Reactions: birds lose morphological diversity due to climate change

Climate change is causing a mass extinction of species, but for birds, this loss of biodiversity has wider implications. In research published in the journal Current Biology, researchers use statistical models to predict that this extinction will decrease morphological diversity among the remaining birds at a faster rate than species loss alone.

Reaction to a new intranasal HIV and SARS-CoV-2 vaccination device tested in animals

US researchers have designed an intranasal vaccination device that is capable of delivering immunising proteins through the mucosal surface. The research, published in Science Translational Medicine, shows that strong antibody responses against viruses such as HIV and SARS-CoV-2 have been achieved in mice and non-human primates.